Search research articles
Contact Us
Filters
Showing results (71-80 of 216) with videos related to
Page
of 22
Sort By:
Journal of Cancer Research and Clinical Oncology
|
May 26, 2020
The effect of proton pump inhibitors on survival outcomes in advanced hepatocellular carcinoma treated with sorafenib
Warit Ruanglertboon, Michael J Sorich, Jessica M Logan, et al.
Journal of Clinical Pharmacology
|
November 27, 2024
Ritonavir May Prolong Sedation but is Unlikely to Increase the Risk of Respiratory Arrest in Patients Requiring Intravenous Midazolam for Procedural Sedation
Jason Arsanious, Angela Rowland, Michael J Sorich, et al.
Cancers
|
October 18, 2018
Risk Factors for Severe Diarrhea with an Afatinib Treatment of Non-Small Cell Lung Cancer: A Pooled Analysis of Clinical Trials
Ashley M Hopkins, Anh-Minh Nguyen, Christos S Karapetis, et al.
Journal of Thrombosis and Haemostasis : JTH
|
May 25, 2010
Prasugrel vs. clopidogrel for cytochrome P450 2C19-genotyped subgroups: integration of the TRITON-TIMI 38 trial data
M J Sorich, A Vitry, M B Ward, et al.
Pharmaceutical Research
|
February 26, 2017
The Routine Clinical use of Pharmacogenetic Tests: What it Will Require?
Mafalda M Dias, Michael J Sorich, Andrew Rowland, et al.
Journal of Oncology
|
July 5, 2021
Survival Outcomes of Nonsmall Cell Lung Cancer Patients Treated with Afatinib Who Are Affected by Early Adverse Events
Jessica M Logan, Doug A Brooks, Andrew Rowland, et al.
International Journal of Cancer
|
June 4, 2020
Patient-reported outcomes as a prognostic marker of survival in patients with advanced nonsmall cell lung cancer treated with immunotherapy
Ashley M Hopkins, Jordan Wagner, Ganessan Kichenadasse, et al.
European Journal of Clinical Pharmacology
|
March 25, 2018
Assessment of inter-racial variability in CYP3A4 activity and inducibility among healthy adult males of Caucasian and South Asian ancestries
Madelé van Dyk, Jean-Claude Marshall, Michael J Sorich, et al.
American Journal of Pharmaceutical Education
|
February 9, 2011
Pharmacists' role in targeted cancer therapy in Australia and implications for pharmacy education
David M Plevin, Helena M Ward, Michael B Ward, et al.
Biomedicines
|
January 21, 2022
Selective Isolation of Liver-Derived Extracellular Vesicles Redefines Performance of miRNA Biomarkers for Non-Alcoholic Fatty Liver Disease
Lauren A Newman, Zivile Useckaite, Jillian Johnson, et al.
Page
of 22
Search research articles
Search
Showing results (71-80 of 216) with videos related to
Sort By:
Page
of 22
Journal of Cancer Research and Clinical Oncology
|
May 26, 2020
The effect of proton pump inhibitors on survival outcomes in advanced hepatocellular carcinoma treated with sorafenib
Warit Ruanglertboon, Michael J Sorich, Jessica M Logan, et al.
Journal of Clinical Pharmacology
|
November 27, 2024
Ritonavir May Prolong Sedation but is Unlikely to Increase the Risk of Respiratory Arrest in Patients Requiring Intravenous Midazolam for Procedural Sedation
Jason Arsanious, Angela Rowland, Michael J Sorich, et al.
Cancers
|
October 18, 2018
Risk Factors for Severe Diarrhea with an Afatinib Treatment of Non-Small Cell Lung Cancer: A Pooled Analysis of Clinical Trials
Ashley M Hopkins, Anh-Minh Nguyen, Christos S Karapetis, et al.
Journal of Thrombosis and Haemostasis : JTH
|
May 25, 2010
Prasugrel vs. clopidogrel for cytochrome P450 2C19-genotyped subgroups: integration of the TRITON-TIMI 38 trial data
M J Sorich, A Vitry, M B Ward, et al.
Pharmaceutical Research
|
February 26, 2017
The Routine Clinical use of Pharmacogenetic Tests: What it Will Require?
Mafalda M Dias, Michael J Sorich, Andrew Rowland, et al.
Journal of Oncology
|
July 5, 2021
Survival Outcomes of Nonsmall Cell Lung Cancer Patients Treated with Afatinib Who Are Affected by Early Adverse Events
Jessica M Logan, Doug A Brooks, Andrew Rowland, et al.
International Journal of Cancer
|
June 4, 2020
Patient-reported outcomes as a prognostic marker of survival in patients with advanced nonsmall cell lung cancer treated with immunotherapy
Ashley M Hopkins, Jordan Wagner, Ganessan Kichenadasse, et al.
European Journal of Clinical Pharmacology
|
March 25, 2018
Assessment of inter-racial variability in CYP3A4 activity and inducibility among healthy adult males of Caucasian and South Asian ancestries
Madelé van Dyk, Jean-Claude Marshall, Michael J Sorich, et al.
American Journal of Pharmaceutical Education
|
February 9, 2011
Pharmacists' role in targeted cancer therapy in Australia and implications for pharmacy education
David M Plevin, Helena M Ward, Michael B Ward, et al.
Biomedicines
|
January 21, 2022
Selective Isolation of Liver-Derived Extracellular Vesicles Redefines Performance of miRNA Biomarkers for Non-Alcoholic Fatty Liver Disease
Lauren A Newman, Zivile Useckaite, Jillian Johnson, et al.
Page
of 22